发明授权
- 专利标题: Psychiatric disorder therapy control
- 专利标题(中): 精神障碍治疗控制
-
申请号: US12425903申请日: 2009-04-17
-
公开(公告)号: US09333350B2公开(公告)日: 2016-05-10
- 发明人: Mark T. Rise , Jonathon E. Giftakis , Paul H. Stypulkowski , Timothy J. Denison , Nathan A. Torgerson
- 申请人: Mark T. Rise , Jonathon E. Giftakis , Paul H. Stypulkowski , Timothy J. Denison , Nathan A. Torgerson
- 申请人地址: US MN Minneapolis
- 专利权人: Medtronic, Inc.
- 当前专利权人: Medtronic, Inc.
- 当前专利权人地址: US MN Minneapolis
- 代理机构: Shumaker & Sieffert, P.A.
- 主分类号: A61N1/00
- IPC分类号: A61N1/00 ; A61N1/36 ; A61B5/16 ; A61B5/01 ; A61B5/0488 ; A61B5/08 ; A61B5/00
摘要:
A therapy system for managing a psychiatric disorder of the patient may be controlled based on a patient mood state. Therapy may be delivered to a patient according to a therapy program, and a physiological parameter of the patient may be monitored during or after therapy delivery. The patient mood state may be determined based on the monitored physiological parameter, and the therapy delivery may be controlled based on the determined mood state. In some embodiments, the therapy delivery is stopped prior to determining the patient mood state and the therapy delivery is restarted upon detecting a negative mood state. In other embodiments, therapy delivery is delivered until a positive mood state is detected, at which point the therapy delivery may be stopped.
公开/授权文献
- US20090264956A1 PSYCHIATRIC DISORDER THERAPY CONTROL 公开/授权日:2009-10-22
信息查询